Home Mogling Bio

Mogling Bio

In operation
Seed Round Financing
Biotechnology Researcher
Basic
Enterprise Profile

Basic Information

Mogling Bio is developing new pharmacological approaches to rejuvenate aged stem cells. As we age, the internal structure of blood cell-forming stem cells, also known as hematopoietic stem cells (HSCs), becomes disordered. This leads to impaired production of blood and immune cells and can result in leukemia and other blood disorders.
Mogling Bio Inc.
Wilmington,Delaware,United States of America
unclear
--
juergen.reess@moglingbio.com

Enterprise Profile

Industrial Sector
CXO (Pharmaceutical Outsourcing Organization)
Technology
Cell Technology Stem Cell Technology